Publication | Open Access
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections
19
Citations
15
References
2022
Year
The safety profile of dalbavancin was consistent in children and adults with ABSSSI. No new safety signals were identified.
| Year | Citations | |
|---|---|---|
Page 1
Page 1